Israel’s Nextar To Set Up Incubator For Medical Cannabis

November 12, 2017 | Israeli pharmaceutical company Nextar Chempharma Solutions will set up an incubator and development center for medical cannabis products, accepting at least six companies per year for the project with initial investment of between $100,000 and $400,000, according to a report in Globes. Nextar will provide a variety of services to the participating companies, “including laboratory and analytic testing, business development, and clinical trial management services.” Nextar will also provide cannabis development services to external companies and will independently develop its own cannabis products, according to the report which added that the company has signed an initial cooperation deal Australia’s Budding Tech, an organization that works in the medical cannabis sector. Nextar is excepted to invest $5 million in the venture.